文献速递其他结缔组织病

TLR8通过激活皮肤成纤维细胞加重系统性硬化症皮肤炎症与纤维化

TLR8 aggravates skin inflammation and fibrosis by activating skin fibroblasts in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

本研究基于公共数据集分析并在系统性硬化症(SSc)患者皮肤组织和成纤维细胞中验证TLR8表达,通过过表达载体、激活剂VTX-2337、抑制剂cu-cpt-8m和TLR8 siRNA在成纤维细胞中探讨TLR8在炎症和纤维化中的作用,并在博来霉素诱导的小鼠皮肤炎症与纤维化模型中验证。结果显示SSc皮肤组织和肌成纤维细胞中TLR8水平显著升高且TLR8通路显著激活,TLR8通过MAPK、NF-κB和SMAD2/3通路诱导皮肤纤维化和炎症,皮下注射cu-cpt-8m可显著减轻博来霉素诱导的小鼠皮肤炎症和纤维化。

要点

  • SSc患者皮肤组织和肌成纤维细胞中TLR8水平显著升高,TLR8通路显著激活。
  • TLR8过表达或激活可上调皮肤成纤维细胞中IL-6、IL-1β、COL I、COL III和α-SMA。
  • TLR8抑制剂cu-cpt-8m皮下注射可显著减轻博来霉素诱导的小鼠皮肤炎症和纤维化。

核心结论

  • TLR8可能成为改善SSc皮肤炎症和纤维化治疗策略的有前景的治疗靶点。

研究设计与样本

  • 基于公共数据集分析TLR8表达,并在SSc患者皮肤组织和皮肤成纤维细胞中验证。
  • 使用TLR8过表达载体、激活剂VTX-2337、抑制剂cu-cpt-8m和TLR8 siRNA在皮肤成纤维细胞中研究TLR8在炎症和纤维化中的作用。
  • 在博来霉素诱导的小鼠皮肤炎症和纤维化模型中进一步验证TLR8的致病作用。

主要发现

  • SSc皮肤组织和肌成纤维细胞中TLR8水平显著升高,同时TLR8通路显著激活。
  • 体外研究中,通过重组质粒或VTX-2337过表达或激活TLR8可上调皮肤成纤维细胞中IL-6、IL-1β、COL I、COL III和α-SMA。
  • TLR8-siRNA和cu-cpt-8m均可逆转TLR8激活成纤维细胞中观察到的表型。
  • 机制上,TLR8以依赖MAPK、NF-κB和SMAD2/3通路的方式诱导皮肤纤维化和炎症。
  • 皮下注射cu-cpt-8m可显著减轻博来霉素诱导的小鼠皮肤炎症和纤维化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Innate immunity significantly contributes to SSc pathogenesis. TLR8 is an important innate immune mediator that is implicated in autoimmunity and fibrosis. However, the expression, mechanism of action, and pathogenic role of TLR8 in SSc remain unclear. The aim of this study was to explore the roles and underlying mechanisms of TLR8 in SSc. METHODS: The expression of TLR8 was analysed, based on a public dataset, and then verified in skin tissues and skin fibroblasts of SSc patients. The role of TLR8 in inflammation and fibrosis was investigated using a TLR8-overexpression vector, activator (VTX-2337), inhibitor (cu-cpt-8m), and TLR8 siRNA in skin fibroblasts. The pathogenic role of TLR8 in skin inflammation and fibrosis was further validated in a bleomycin (BLM)-induced mouse skin inflammation and fibrosis model. RESULTS: TLR8 levels were significantly elevated in SSc skin tissues and myofibroblasts, along with significant activation of the TLR8 pathway. In vitro studies showed that overexpression or activation of TLR8 by a recombinant plasmid or VTX-2337 upregulated IL-6, IL-1β, COL I, COL III and α-SMA in skin fibroblasts. Consistently, both TLR8-siRNA and cu-cpt-8m reversed the phenotypes observed in TLR8-activating fibroblasts. Mechanistically, TLR8 induces skin fibrosis and inflammation in a manner dependent on the MAPK, NF-κB and SMAD2/3 pathways. Subcutaneous injection of cu-cpt-8m significantly alleviated BLM-induced skin inflammation and fibrosis in vivo. CONCLUSION: TLR8 might be a promising therapeutic target for improving the treatment strategy for skin inflammation and fibrosis in SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kong X, Jiang S, He Q, et al. TLR8 aggravates skin inflammation and fibrosis by activating skin fibroblasts in systemic sclerosis. Rheumatology (Oxford). 2024. PMID: 37665747. doi:10.1093/rheumatology/kead456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。